sulindac-sulfone and Colitis--Ulcerative

sulindac-sulfone has been researched along with Colitis--Ulcerative* in 1 studies

Reviews

1 review(s) available for sulindac-sulfone and Colitis--Ulcerative

ArticleYear
Unveiling the key genes, environmental toxins, and drug exposures in modulating the severity of ulcerative colitis: a comprehensive analysis.
    Frontiers in immunology, 2023, Volume: 14

    As yet, the genetic abnormalities involved in the exacerbation of Ulcerative colitis (UC) have not been adequately explored based on bioinformatic methods.. The gene microarray data and clinical information were downloaded from Gene Expression Omnibus (GEO) repository. The scale-free gene co-expression networks were constructed by R package "WGCNA". Gene enrichment analysis was performed. Using WGCNA and random forest algorithm, we identified 9 gene signatures of the exacerbation of UC. A novel genotyping scheme was constructed to predict the severity of UC and screen UC patients suitable for CS-IV treatment. Subsequently, we identified a small molecule drug (Exisulind) with potential therapeutic effects for UC. Thus, our study provided new ideas and materials for the personalized clinical treatment plans for patients with UC.

    Topics: Colitis, Ulcerative; Gene Regulatory Networks; Humans; Leukocyte Immunoglobulin-like Receptor B1; Molecular Docking Simulation; Nuclear Proteins

2023